STAGING AND THERAPY OF CRYPTOGENIC FIBROSING ALVEOLITIS

被引:9
作者
TURNERWARWICK, M
机构
关键词
D O I
10.1378/chest.89.3_Supplement.148S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:S148 / S150
页数:3
相关论文
共 12 条
[1]   CRYPTOGENIC FIBROSING ALVEOLITIS - PREDICTION OF FIBROGENIC ACTIVITY FROM IMMUNOHISTOCHEMICAL STUDIES OF COLLAGEN TYPES IN LUNG-BIOPSY SPECIMENS [J].
BATEMAN, ED ;
TURNERWARWICK, M ;
HASLAM, PL ;
ADELMANNGRILL, BC .
THORAX, 1983, 38 (02) :93-101
[2]   BRONCHOALVEOLAR LAVAGE IN PULMONARY FIBROSIS - COMPARISON OF CELLS OBTAINED WITH LUNG-BIOPSY AND CLINICAL-FEATURES [J].
HASLAM, PL ;
TURTON, CWG ;
HEARD, B ;
LUKOSZEK, A ;
COLLINS, JV ;
SALSBURY, AJ ;
TURNERWARWICK, M .
THORAX, 1980, 35 (01) :9-18
[3]  
HUNNINGHAKE GW, 1981, AM REV RESPIR DIS, V123, P407
[4]  
KIRK JME, 1984, THORAX, V39, P725
[5]  
LINE BR, 1981, AM REV RESPIR DIS, V123, P440
[6]  
PANTIN CFA, 1984, THORAX, V39, P709
[7]  
RUDD RM, 1981, AM REV RESPIR DIS, V124, P1
[8]   APPROACHES TO THERAPY [J].
TURNERWARWICK, M .
SEMINARS IN RESPIRATORY MEDICINE, 1984, 6 (01) :92-102
[9]   CRYPTOGENIC FIBROSING ALVEOLITIS - RESPONSE TO CORTICOSTEROID TREATMENT AND ITS EFFECT ON SURVIVAL [J].
TURNERWARWICK, M ;
BURROWS, B ;
JOHNSON, A .
THORAX, 1980, 35 (08) :593-599
[10]   CRYPTOGENIC FIBROSING ALVEOLITIS - CLINICAL-FEATURES AND THEIR INFLUENCE ON SURVIVAL [J].
TURNERWARWICK, M ;
BURROWS, B ;
JOHNSON, A .
THORAX, 1980, 35 (03) :171-180